1-5 of 5
Laurens V. Beerepoot
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Patients with Rare Cancers in the Drug Rediscovery Protocol (DRUP) Benefit from Genomics-Guided Treatment

Louisa R. Hoes, Jade M. van Berge Henegouwen, Hanneke van der Wijngaart, Laurien J. Zeverijn, Daphne L. van der Velden, Joris van de Haar, Paul Roepman, Wendy J. de Leng, Anne M.L. Jansen, Erik van Werkhoven, Vincent van der Noort, Alwin D.R. Huitema, Eelke H. Gort, Jan Willem B. de Groot, Emile D. Kerver, Derk Jan de Groot, Frans Erdkamp, Laurens V. Beerepoot, Mathijs P. Hendriks, Egbert F. Smit, Winette T.A. van der Graaf, Carla M.L. van Herpen, Mariette Labots, Ann Hoeben, Hans Morreau, Martijn P. Lolkema, Edwin Cuppen, Hans Gelderblom, Henk M.W. Verheul, Emile E. Voest
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (7): 1402–1411.
https://doi.org/10.1158/1078-0432.CCR-21-3752
Published: 01 April 2022
View article titled, Patients with Rare Cancers in the Drug Rediscovery Protocol (DRUP) Benefit from Genomics-Guided Treatment
Open the PDF for Patients with Rare Cancers in the Drug Rediscovery Protocol (DRUP) Benefit from Genomics-Guided Treatment in another window
Includes: Supplementary data
Journal Articles

Lysosomal Sequestration of Sunitinib: A Novel Mechanism of Drug Resistance

Kristy J. Gotink, Henk J. Broxterman, Mariette Labots, Richard R. de Haas, Henk Dekker, Richard J. Honeywell, Michelle A. Rudek, Laurens V. Beerepoot, René J. Musters, Gerrit Jansen, Arjan W. Griffioen, Yehuda G. Assaraf, Roberto Pili, Godefridus J. Peters, Henk M.W. Verheul
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (23): 7337–7346.
https://doi.org/10.1158/1078-0432.CCR-11-1667
Published: 30 November 2011
View article titled, Lysosomal Sequestration of Sunitinib: A Novel Mechanism of Drug Resistance
Open the PDF for Lysosomal Sequestration of Sunitinib: A Novel Mechanism of Drug Resistance in another window
Includes: Supplementary data
Journal Articles

Phase I Pharmacokinetic and Pharmacodynamic Study of the Oral Protein Kinase C β-Inhibitor Enzastaurin in Combination with Gemcitabine and Cisplatin in Patients with Advanced Cancer

Jeany M. Rademaker-Lakhai, Laurens V. Beerepoot, Niven Mehra, Sandra A. Radema, Rianne van Maanen, Joost S. Vermaat, Els O. Witteveen, Carla M. Visseren-Grul, Luna Musib, Nathan Enas, Gertjan van Hal, Jos H. Beijnen, Jan H.M. Schellens, Emile E. Voest
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (15): 4474–4481.
https://doi.org/10.1158/1078-0432.CCR-06-2912
Published: 01 August 2007
View article titled, Phase I Pharmacokinetic and Pharmacodynamic Study of the Oral Protein Kinase C β-Inhibitor Enzastaurin in Combination with Gemcitabine and Cisplatin in Patients with Advanced Cancer
Open the PDF for Phase I Pharmacokinetic and Pharmacodynamic Study of the Oral Protein Kinase C β-Inhibitor Enzastaurin in Combination with Gemcitabine and Cisplatin in Patients with Advanced Cancer in another window
Journal Articles

Progenitor Marker CD133 mRNA Is Elevated in Peripheral Blood of Cancer Patients with Bone Metastases

Niven Mehra, Maarten Penning, Jolanda Maas, Laurens V. Beerepoot, Nancy van Daal, Carla H. van Gils, Rachel H. Giles, Emile E. Voest
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (16): 4859–4866.
https://doi.org/10.1158/1078-0432.CCR-06-0422
Published: 16 August 2006
View article titled, Progenitor Marker CD133 mRNA Is Elevated in Peripheral Blood of Cancer Patients with Bone Metastases
Open the PDF for Progenitor Marker CD133 mRNA Is Elevated in Peripheral Blood of Cancer Patients with Bone Metastases in another window
Journal Articles

Recombinant Human Angiostatin by Twice-Daily Subcutaneous Injection in Advanced Cancer: A Pharmacokinetic and Long-Term Safety Study

Laurens V. Beerepoot, Els O. Witteveen, Gerard Groenewegen, William E. Fogler, B. Kim Leel Sim, Carolyn Sidor, Bernard A. Zonnenberg, Franz Schramel, Martijn F. B. G. Gebbink, Emile E. Voest
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (11): 4025–4033.
Published: 30 September 2003
View article titled, Recombinant Human Angiostatin by Twice-Daily Subcutaneous Injection in Advanced Cancer: <subtitle>A Pharmacokinetic and Long-Term Safety Study</subtitle>
Open the PDF for Recombinant Human Angiostatin by Twice-Daily Subcutaneous Injection in Advanced Cancer: <subtitle>A Pharmacokinetic and Long-Term Safety Study</subtitle> in another window